IL155677A0 - Cyclization process step in the making of quinolones and naphthyridines - Google Patents
Cyclization process step in the making of quinolones and naphthyridinesInfo
- Publication number
- IL155677A0 IL155677A0 IL15567701A IL15567701A IL155677A0 IL 155677 A0 IL155677 A0 IL 155677A0 IL 15567701 A IL15567701 A IL 15567701A IL 15567701 A IL15567701 A IL 15567701A IL 155677 A0 IL155677 A0 IL 155677A0
- Authority
- IL
- Israel
- Prior art keywords
- making
- naphthyridines
- quinolones
- process step
- cyclization process
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 150000005054 naphthyridines Chemical class 0.000 title 1
- 150000007660 quinolones Chemical class 0.000 title 1
- 238000007363 ring formation reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25563300P | 2000-12-14 | 2000-12-14 | |
| PCT/US2001/048536 WO2002048113A1 (en) | 2000-12-14 | 2001-12-07 | Cyclization process step in the making of quinolones and naphthyridines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL155677A0 true IL155677A0 (en) | 2003-11-23 |
Family
ID=22969207
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15567701A IL155677A0 (en) | 2000-12-14 | 2001-12-07 | Cyclization process step in the making of quinolones and naphthyridines |
| IL155677A IL155677A (en) | 2000-12-14 | 2003-04-30 | Stage cyclization in the process of preparing quinolones and naphthyridines |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL155677A IL155677A (en) | 2000-12-14 | 2003-04-30 | Stage cyclization in the process of preparing quinolones and naphthyridines |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1343766B1 (cs) |
| JP (2) | JP4417007B2 (cs) |
| KR (1) | KR100603163B1 (cs) |
| CN (1) | CN1232508C (cs) |
| AT (1) | ATE300522T1 (cs) |
| AU (2) | AU2905702A (cs) |
| BR (1) | BR0116229A (cs) |
| CA (1) | CA2427831C (cs) |
| CZ (1) | CZ20031379A3 (cs) |
| DE (1) | DE60112325T2 (cs) |
| DK (1) | DK1343766T3 (cs) |
| ES (1) | ES2247190T3 (cs) |
| HU (1) | HUP0303991A3 (cs) |
| IL (2) | IL155677A0 (cs) |
| MX (1) | MXPA03005338A (cs) |
| NO (1) | NO325236B1 (cs) |
| NZ (1) | NZ525569A (cs) |
| PL (1) | PL207394B1 (cs) |
| WO (1) | WO2002048113A1 (cs) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100735587B1 (ko) * | 2002-08-05 | 2007-07-04 | 더 프록터 앤드 갬블 캄파니 | 퀴놀론계 항생제 중간체의 제조 방법 |
| US6803469B2 (en) * | 2002-08-05 | 2004-10-12 | The Procter & Gamble Company | Process for preparing quinolone antibiotic intermediates |
| SK2662004A3 (sk) | 2002-11-20 | 2005-06-02 | Japan Tobacco, Inc. | Zlúčenina s obsahom 4-oxochinolínu a jej použitie ako inhibítora integráz |
| US7402674B2 (en) | 2004-01-31 | 2008-07-22 | Sanofi-Aventis Deutschland Gmbh, | 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
| ES2531190T3 (es) | 2006-03-06 | 2015-03-11 | Japan Tobacco Inc | Método para producir un compuesto de 4-oxoquinolina |
| WO2007102499A1 (ja) | 2006-03-06 | 2007-09-13 | Japan Tobacco Inc. | ４－オキソキノリン化合物の製造方法 |
| WO2008033836A2 (en) * | 2006-09-12 | 2008-03-20 | Gilead Sciences, Inc. | Process and intermediates for preparing integrase inhibitors |
| US8658183B2 (en) | 2007-08-09 | 2014-02-25 | Taigen Biotechnology Company, Ltd. | Antimicrobial parenteral formulation |
| AR068403A1 (es) | 2007-09-11 | 2009-11-18 | Gilead Sciences Inc | Proceso e intermediarios para la preparacion de inhibidores de integrasa |
| US8211909B2 (en) | 2008-07-01 | 2012-07-03 | Taigen Biotechnology Co., Ltd. | Treatment of antibiotic-resistant bacteria infection |
| AU2013296289B2 (en) | 2012-08-03 | 2017-10-05 | Gilead Sciences, Inc. | Process and intermediates for preparing integrase inhibitors |
| KR102912926B1 (ko) | 2018-07-19 | 2026-01-14 | 린트필드 리미티드 | 티오크산톤 유도체 및 이를 포함하는 조성물 및 상기 조성물을 포함하는 패턴 형성 방법｛Thioxanthone derivatives, composition comprising the same and pattern forming method comprising said composition｝ |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2196539C (en) * | 1994-08-02 | 2001-05-15 | The Procter & Gamble Company | Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
| WO1996004247A1 (en) * | 1994-08-02 | 1996-02-15 | The Procter & Gamble Company | Process for making antimicrobial compounds |
-
2001
- 2001-12-07 MX MXPA03005338A patent/MXPA03005338A/es active IP Right Grant
- 2001-12-07 CN CNB018207146A patent/CN1232508C/zh not_active Expired - Lifetime
- 2001-12-07 ES ES01990192T patent/ES2247190T3/es not_active Expired - Lifetime
- 2001-12-07 NZ NZ525569A patent/NZ525569A/en not_active IP Right Cessation
- 2001-12-07 KR KR1020037007905A patent/KR100603163B1/ko not_active Expired - Fee Related
- 2001-12-07 WO PCT/US2001/048536 patent/WO2002048113A1/en not_active Ceased
- 2001-12-07 EP EP01990192A patent/EP1343766B1/en not_active Expired - Lifetime
- 2001-12-07 BR BR0116229-2A patent/BR0116229A/pt not_active IP Right Cessation
- 2001-12-07 IL IL15567701A patent/IL155677A0/xx active IP Right Grant
- 2001-12-07 DK DK01990192T patent/DK1343766T3/da active
- 2001-12-07 AU AU2905702A patent/AU2905702A/xx active Pending
- 2001-12-07 AT AT01990192T patent/ATE300522T1/de active
- 2001-12-07 PL PL363355A patent/PL207394B1/pl not_active IP Right Cessation
- 2001-12-07 JP JP2002549644A patent/JP4417007B2/ja not_active Expired - Fee Related
- 2001-12-07 DE DE60112325T patent/DE60112325T2/de not_active Expired - Lifetime
- 2001-12-07 AU AU2002229057A patent/AU2002229057B2/en not_active Ceased
- 2001-12-07 CZ CZ20031379A patent/CZ20031379A3/cs unknown
- 2001-12-07 HU HU0303991A patent/HUP0303991A3/hu unknown
- 2001-12-07 CA CA002427831A patent/CA2427831C/en not_active Expired - Fee Related
-
2003
- 2003-04-30 IL IL155677A patent/IL155677A/en not_active IP Right Cessation
- 2003-06-12 NO NO20032667A patent/NO325236B1/no not_active IP Right Cessation
-
2009
- 2009-10-05 JP JP2009231801A patent/JP2010001315A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE60112325T2 (de) | 2006-05-24 |
| JP4417007B2 (ja) | 2010-02-17 |
| WO2002048113A1 (en) | 2002-06-20 |
| ES2247190T3 (es) | 2006-03-01 |
| AU2905702A (en) | 2002-06-24 |
| NO20032667D0 (no) | 2003-06-12 |
| BR0116229A (pt) | 2003-11-04 |
| KR100603163B1 (ko) | 2006-07-24 |
| HUP0303991A3 (en) | 2012-09-28 |
| CZ20031379A3 (cs) | 2003-11-12 |
| JP2010001315A (ja) | 2010-01-07 |
| CA2427831C (en) | 2009-08-18 |
| PL363355A1 (en) | 2004-11-15 |
| AU2002229057B2 (en) | 2005-04-21 |
| CA2427831A1 (en) | 2002-06-20 |
| NO20032667L (no) | 2003-08-14 |
| DK1343766T3 (da) | 2005-10-31 |
| HUP0303991A2 (hu) | 2004-04-28 |
| CN1232508C (zh) | 2005-12-21 |
| EP1343766A1 (en) | 2003-09-17 |
| PL207394B1 (pl) | 2010-12-31 |
| ATE300522T1 (de) | 2005-08-15 |
| EP1343766B1 (en) | 2005-07-27 |
| NO325236B1 (no) | 2008-03-03 |
| MXPA03005338A (es) | 2003-10-06 |
| CN1481365A (zh) | 2004-03-10 |
| NZ525569A (en) | 2004-09-24 |
| JP2004515542A (ja) | 2004-05-27 |
| IL155677A (en) | 2009-02-11 |
| DE60112325D1 (de) | 2005-09-01 |
| KR20030063420A (ko) | 2003-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ536141A (en) | Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles | |
| IL155677A0 (en) | Cyclization process step in the making of quinolones and naphthyridines | |
| WO2002032898A3 (de) | Neue anticholinergika, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| SG141459A1 (en) | Novel quinoline derivatives | |
| ES2159488A1 (es) | Procedimiento para la preparacion de derivados de pirimidona con actividad antifugica. | |
| MXPA04001647A (es) | Proceso para la preparacion de un derivado de 14-hidroxinormorfinona. | |
| MXPA04000382A (es) | Proceso para preparacion de l-ribavirina. | |
| WO2003082757A3 (en) | Methods of modifying fibers | |
| IL154014A0 (en) | Process for the preparation of 2-aminoethylpyridines | |
| CA2362217A1 (en) | Process for preparing phenylpyrazole pesticidal intermediates | |
| ATE339427T1 (de) | Herstellung von sekundären aminoisobutylalkoxysilanen | |
| IL156141A0 (en) | A process for the preparation of taxan derivatives | |
| MXPA03011401A (es) | Procedimiento para la preparacion de derivados de ciclohexanol. | |
| MXPA04004937A (es) | Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles. | |
| GB0019124D0 (en) | Novel process | |
| MXPA02001406A (es) | Heterociclilos-2h-cromenos substituidos. | |
| AU2002233708A1 (en) | Process for producing quinoline-3-carboxylic acid compound | |
| GB0103240D0 (en) | Organic compounds | |
| GB9920959D0 (en) | Novel process | |
| TR200001819T2 (tr) | COPD tedavi yöntemi. | |
| HU0201262D0 (cs) | ||
| TR200200995T2 (tr) | 7-amino-3-metksimetil-3-sefem-4-karbosilik asitin hazırlanmasına yönelik proses. | |
| SE0000382D0 (sv) | New process | |
| AP2001002195A0 (en) | Novel process for the preparation of pyrazolopyrimidinones. | |
| DK1694684T3 (da) | Fremgangsmåde til fremstilling af camptothecinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |